☰

Mary Sue O'Dorisio, MD, PhD - Publications

Affiliations: 
Pediatrics University of Iowa Carver College of Medicine, Iowa City, IA, United States 
Area:
Pediatrics - Hematology Oncology
Website:
https://medicine.uiowa.edu/pediatrics/profile/m-sue-odorisio
Tree Info Similar researchers PubMed Report error

56 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Ghobrial SN, Menda Y, Zamba GK, Mott SL, Gaimari-Varner K, Dick D, Dillon J, Howe JR, Graham M, Sunderland J, Bellizzi A, O'Dorisio TM, O'Dorisio MS. Prospective Analysis of the Impact of 68Ga-DOTATOC Positron Emission Tomography-Computerized Axial Tomography on Management of Pancreatic and Small Bowel Neuroendocrine Tumors. Pancreas. PMID 32769854 DOI: 10.1097/Mpa.0000000000001625  0.496
2019 Jha A, de Luna K, Balili CA, Millo C, Paraiso CA, Ling A, Gonzales MK, Viana B, Alrezk R, Adams KT, Tena I, Chen A, Neuzil J, Raygada M, Kebebew E, et al. Clinical, Diagnostic, and Treatment Characteristics of -Related Metastatic Pheochromocytoma and Paraganglioma. Frontiers in Oncology. 9: 53. PMID 30854332 DOI: 10.3389/Fonc.2019.00053  0.459
2018 Madsen MT, Menda Y, O'Dorisio TM, O'Dorisio MS. Technical Note: Single time point dose estimate for exponential clearance. Medical Physics. PMID 29577338 DOI: 10.1002/Mp.12886  0.4
2018 Menda Y, Madsen MT, O'Dorisio TM, Sunderland J, Watkins LG, Dillon JS, Mott SL, Schultz MK, Zamba GKD, Bushnell DL, O'Dorisio MS. Y-DOTATOC Dosimetry-Based Personalized Peptide Receptor Radionuclide Therapy. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29523629 DOI: 10.2967/Jnumed.117.202903  0.453
2017 Abongwa C, Mott S, Schafer B, McNeely P, Abusin G, O'Dorisio T, Zamba G, O'Dorisio MS, Menda Y. Safety and accuracy of Ga-DOTATOC PET/CT in children and young adults with solid tumors. American Journal of Nuclear Medicine and Molecular Imaging. 7: 228-235. PMID 29181270  0.47
2017 Menda Y, O'Dorisio TM, Howe J, Schultz MK, Dillon J, Dick D, Watkins LG, Ginader T, Bushnell DL, Sunderland J, Zamba GK, Graham MM, O'Dorisio MS. Localization of Unknown Primary Site with 68Ga-DOTATOC PET/CT in Patients with Metastatic Neuroendocrine Tumor. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 28153957 DOI: 10.2967/Jnumed.116.180984  0.521
2016 Sharma N, Naraev BG, Engelman EG, Zimmerman MB, Bushnell DL, OʼDorisio TM, OʼDorisio MS, Menda Y, Müller-Brand J, Howe JR, Halfdanarson TR. Peptide Receptor Radionuclide Therapy Outcomes in a North American Cohort With Metastatic Well-Differentiated Neuroendocrine Tumors. Pancreas. PMID 27759712 DOI: 10.1097/MPA.0000000000000734  0.52
2014 Bushnell DL, Madsen MT, O'cdorisio T, Menda Y, Muzahir S, Ryan R, O'dorisio MS. Feasibility and advantage of adding (131)I-MIBG to (90)Y-DOTATOC for treatment of patients with advanced stage neuroendocrine tumors. Ejnmmi Research. 4: 38. PMID 26116109 DOI: 10.1186/S13550-014-0038-2  0.31
2014 Sherman SK, Maxwell JE, O'Dorisio MS, O'Dorisio TM, Howe JR. Pancreastatin predicts survival in neuroendocrine tumors. Annals of Surgical Oncology. 21: 2971-80. PMID 24752611 DOI: 10.1245/s10434-014-3728-0  0.53
2014 Sherman SK, Maxwell JE, Carr JC, Wang D, O'Dorisio MS, O'Dorisio TM, Howe JR. GIPR expression in gastric and duodenal neuroendocrine tumors. The Journal of Surgical Research. 190: 587-93. PMID 24565507 DOI: 10.1016/J.Jss.2014.01.044  0.552
2013 Sherman SK, Carr JC, Wang D, O'Dorisio MS, O'Dorisio TM, Howe JR. Gastric inhibitory polypeptide receptor (GIPR) is a promising target for imaging and therapy in neuroendocrine tumors. Surgery. 154: 1206-13; discussion . PMID 24238043 DOI: 10.1016/j.surg.2013.04.052  0.553
2013 Carr JC, Sherman SK, Wang D, Dahdaleh FS, Bellizzi AM, O'Dorisio MS, O'Dorisio TM, Howe JR. Overexpression of membrane proteins in primary and metastatic gastrointestinal neuroendocrine tumors. Annals of Surgical Oncology. 20: S739-46. PMID 24114056 DOI: 10.1245/s10434-013-3318-6  0.551
2013 Menda Y, Ponto LL, Schultz MK, Zamba GK, Watkins GL, Bushnell DL, Madsen MT, Sunderland JJ, Graham MM, O'Dorisio TM, O'Dorisio MS. Repeatability of gallium-68 DOTATOC positron emission tomographic imaging in neuroendocrine tumors. Pancreas. 42: 937-43. PMID 23587853 DOI: 10.1097/Mpa.0B013E318287Ce21  0.458
2013 Bodei L, Mueller-Brand J, Baum RP, Pavel ME, Hörsch D, O'Dorisio MS, O'Dorisio TM, O'Dorisiol TM, Howe JR, Cremonesi M, Kwekkeboom DJ, Zaknun JJ. The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours. European Journal of Nuclear Medicine and Molecular Imaging. 40: 800-16. PMID 23389427 DOI: 10.1007/s00259-012-2330-6  0.482
2012 Carr JC, Boese EA, Spanheimer PM, Dahdaleh FS, Martin M, Calva D, Schafer B, Thole DM, Braun T, O'Dorisio TM, O'Dorisio MS, Howe JR. Differentiation of small bowel and pancreatic neuroendocrine tumors by gene-expression profiling. Surgery. 152: 998-1007. PMID 23158174 DOI: 10.1016/J.Surg.2012.08.040  0.511
2011 Navalkele P, O'Dorisio MS, O'Dorisio TM, Zamba GK, Lynch CF. Incidence, survival, and prevalence of neuroendocrine tumors versus neuroblastoma in children and young adults: nine standard SEER registries, 1975-2006. Pediatric Blood & Cancer. 56: 50-7. PMID 21108439 DOI: 10.1002/Pbc.22559  0.497
2010 Menda Y, O'Dorisio MS, Kao S, Khanna G, Michael S, Connolly M, Babich J, O'Dorisio T, Bushnell D, Madsen M. Phase I trial of 90Y-DOTATOC therapy in children and young adults with refractory solid tumors that express somatostatin receptors. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 1524-31. PMID 20847174 DOI: 10.2967/Jnumed.110.075226  0.518
2010 Shutt DC, O'Dorisio MS, Aykin-Burns N, Spitz DR. 2-deoxy-D-glucose induces oxidative stress and cell killing in human neuroblastoma cells. Cancer Biology & Therapy. 9: 853-61. PMID 20364116 DOI: 10.4161/Cbt.9.11.11632  0.543
2010 Bushnell DL, O'Dorisio TM, O'Dorisio MS, Menda Y, Hicks RJ, Van Cutsem E, Baulieu JL, Borson-Chazot F, Anthony L, Benson AB, Oberg K, Grossman AB, Connolly M, Bouterfa H, Li Y, et al. 90Y-edotreotide for metastatic carcinoid refractory to octreotide. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 1652-9. PMID 20194865 DOI: 10.1200/Jco.2009.22.8585  0.472
2010 O'Dorisio TM, Krutzik SR, Woltering EA, Lindholm E, Joseph S, Gandolfi AE, Wang YZ, Boudreaux JP, Vinik AI, Go VL, Howe JR, Halfdanarson T, O'Dorisio MS, Mamikunian G. Development of a highly sensitive and specific carboxy-terminal human pancreastatin assay to monitor neuroendocrine tumor behavior. Pancreas. 39: 611-6. PMID 20124939 DOI: 10.1097/Mpa.0B013E3181C68D7A  0.493
2010 Anthony LB, Chester MM, Brown BJ, Michael SL, Seward JR, O'Dorisio MS, O'Dorisio TM. An Open-Label, Phase II Study Evaluating the Safety and Efficacy of PTK787/ZK222584 in Patients With Metastatic Neuroendocrine Tumors That Have Evidence of Progressive Disease or an Increase in Disease Related Syndrome Symptoms Pancreas. 39: 271. DOI: 10.1097/Mpa.0B013E3181C8Fc3E  0.456
2010 O'Dorisio MS, Menda Y, Michael S, Kao S, Khanna G, Connelly M, Babich J, O'Dorisio T, Bushnell D, Madsen M. Phase I Trial of 90Y-DOTA-tyr 3-Octreotide in Children and Young Adults Pancreas. 39: 278-279. DOI: 10.1097/01.Mpa.0000363936.21412.5D  0.397
2010 Navalkele P, O'Dorisio M, O'Dorisio TM, Lynch CF. Neuroendocrine Tumors in Children and Young Adults Pancreas. 39: 278. DOI: 10.1097/01.Mpa.0000363933.98540.E2  0.486
2008 Khanna G, Bushnell D, O'Dorisio MS. Utility of radiolabeled somatostatin receptor analogues for staging/restaging and treatment of somatostatin receptor-positive pediatric tumors. The Oncologist. 13: 382-9. PMID 18448552 DOI: 10.1634/Theoncologist.2007-0175  0.362
2006 Madsen MT, Bushnell DL, Juweid ME, Menda Y, O'Dorisio MS, O'Dorisio T, Besse IM. Potential increased tumor-dose delivery with combined 131I-MIBG and 90Y-DOTATOC treatment in neuroendocrine tumors: a theoretic model. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 47: 660-7. PMID 16595501  0.514
2005 Miller MA, Karacay B, Breslow NE, Li S, O'Dorisio MS, Grundy PE, Sandler AD. Prognostic value of quantifying apoptosis factor expression in favorable histology wilms tumors. Journal of Pediatric Hematology/Oncology. 27: 11-4. PMID 15654272 DOI: 10.1097/01.Mph.0000149961.71266.27  0.307
2004 Frühwald MC, Rickert CH, O'Dorisio MS, Madsen M, Warmuth-Metz M, Khanna G, Paulus W, Kühl J, Jürgens H, Schneider P, Müller HL. Somatostatin receptor subtype 2 is expressed by supratentorial primitive neuroectodermal tumors of childhood and can be targeted for somatostatin receptor imaging. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 2997-3006. PMID 15131035 DOI: 10.1158/1078-0432.Ccr-03-0083  0.328
2003 O'Dorisio MS, O'Dorisio TM. Two-career families: published data and personal reflections. Experimental Biology and Medicine (Maywood, N.J.). 228: 1266-8. PMID 14681541 DOI: 10.1177/153537020322801104  0.352
2003 Cooke HJ, Wang YZ, Wray D, O'Dorisio MS, Woltering EA, Coy DH, Murphy WA, Christofi FL, Gosh P, O'Dorisio TM. A multi-tyrosinated sst1/2 receptor preferring somatostatin agonist inhibits reflex and immune-mediated secretion in the guinea pig colon. Regulatory Peptides. 114: 51-60. PMID 12763640 DOI: 10.1016/S0167-0115(03)00108-3  0.426
2002 O'Dorisio MS, Hauger M, O'Dorisio TM. Age-dependent levels of plasma neuropeptides in normal children. Regulatory Peptides. 109: 189-92. PMID 12409232 DOI: 10.1016/S0167-0115(02)00203-3  0.447
2001 Klisovic DD, O'Dorisio MS, Katz SE, Sall JW, Balster D, O'Dorisio TM, Craig E, Lubow M. Somatostatin receptor gene expression in human ocular tissues: RT-PCR and immunohistochemical study. Investigative Ophthalmology & Visual Science. 42: 2193-201. PMID 11527930  0.445
2001 Watson JC, Balster DA, Gebhardt BM, O'Dorisio TM, O'Dorisio MS, Espenan GD, Drouant GJ, Woltering EA. Growing vascular endothelial cells express somatostatin subtype 2 receptors. British Journal of Cancer. 85: 266-72. PMID 11461088 DOI: 10.1054/bjoc.2001.1881  0.455
2001 Lum SS, Fletcher WS, O'Dorisio MS, Nance RW, Pommier RF, Caprara M. Distribution and functional significance of somatostatin receptors in malignant melanoma. World Journal of Surgery. 25: 407-12. PMID 11344389 DOI: 10.1007/S002680020102  0.353
2000 Albers AR, O'Dorisio MS, Balster DA, Caprara M, Gosh P, Chen F, Hoeger C, Rivier J, Wenger GD, O'Dorisio TM, Qualman SJ. Somatostatin receptor gene expression in neuroblastoma Regulatory Peptides. 88: 61-73. PMID 10706954 DOI: 10.1016/S0167-0115(99)00121-4  0.56
1999 Cuntz MC, Levine EA, O'Dorisio TM, Watson JC, Wray DA, Espenan GD, McKnight C, Meier JR, Weber LJ, Mera R, O'Dorisio MS, Woltering EA. Intraoperative gamma detection of 125I-lanreotide in women with primary breast cancer. Annals of Surgical Oncology. 6: 367-72. PMID 10379857 DOI: 10.1007/s10434-999-0367-y  0.429
1999 Frühwald MC, O'Dorisio MS, Pietsch T, Reubi JC. High expression of somatostatin receptor subtype 2 (sst2) in medulloblastoma: implications for diagnosis and therapy. Pediatric Research. 45: 697-708. PMID 10231868 DOI: 10.1203/00006450-199905010-00016  0.329
1999 Woltering EA, O'Dorisio MS, Murphy WA, Chen F, Drouant GJ, Espenan GD, Fisher DR, Sharma C, Diaco DS, Maloney TM, Fuselier JA, Nelson JA, O'Dorisio TM, Coy DH. Synthesis and characterization of multiply-tyrosinated, multiply-iodinated somatostatin analogs. The Journal of Peptide Research : Official Journal of the American Peptide Society. 53: 201-13. PMID 10195457 DOI: 10.1111/J.1397-002X.1999.00019.X  0.531
1999 Frühwald MC, O'Dorisio MS, Fleitz J, Pietsch T, Reubi JC. Vasoactive intestinal peptide (VIP) and VIP receptors: gene expression and growth modulation in medulloblastoma and other central primitive neuroectodermal tumors of childhood. International Journal of Cancer. 81: 165-73. PMID 10188714 DOI: 10.1002/(Sici)1097-0215(19990412)81:2<165::Aid-Ijc1>3.0.Co;2-0  0.325
1998 Frühwald MC, O'Dorisio MS, Cottingham SL, Qualman SJ, O'Dorisio TM. Neuropeptides in developmental tumors of the central and peripheral nervous system. Annals of the New York Academy of Sciences. 865: 420-6. PMID 9928042 DOI: 10.1111/J.1749-6632.1998.Tb11208.X  0.515
1997 Ellison EC, Schirmer WJ, Olsen JO, Pozderac RV, Hinkle G, Hill T, O'Dorisio TM, O'Dorisio MS. Localization of Neuroendocrine Tumors Using Somatostatin Receptor Imaging With Indium-111-Pentetreotide (OctreoScan). Cancer Control : Journal of the Moffitt Cancer Center. 4: 35-39. PMID 10763002  0.543
1997 Turman MA, O'Dorisio MS, O'Dorisio TM, Apple CA, Albers AR. Somatostatin expression in human renal cortex and mesangial cells. Regulatory Peptides. 68: 15-21. PMID 9094750 DOI: 10.1016/S0167-0115(96)00136-X  0.442
1996 Park SK, O'Dorisio MS, O'Dorisio TM. Vasoactive intestinal polypeptide-secreting tumours: biology and therapy. BaillièRe's Clinical Gastroenterology. 10: 673-96. PMID 9113317 DOI: 10.1016/S0950-3528(96)90018-4  0.417
1996 Fisher WE, Muscarella P, O'Dorisio TM, O'Dorisio MS, Kim JA, Doran TA, Sabourin CL, Schirmer WJ. Expression of the somatostatin receptor subtype-2 gene predicts response of human pancreatic cancer to octreotide. Surgery. 120: 234-40; discussion 2. PMID 8751588 DOI: 10.1016/S0039-6060(96)80293-5  0.534
1996 Park SK, Olson TA, Ercal N, Summers M, O'Dorisio MS. Characterization of vasoactive intestinal peptide receptors on human megakaryocytes and platelets. Blood. 87: 4629-35. PMID 8639831 DOI: 10.1182/Blood.V87.11.4629.Bloodjournal87114629  0.519
1995 Martinez DA, O'Dorisio MS, O'Dorisio TM, Qualman SJ, Caniano DA, Teich S, Besner GE, King DR. Intraoperative detection and resection of occult neuroblastoma: a technique exploiting somatostatin receptor expression. Journal of Pediatric Surgery. 30: 1580-9. PMID 8583329 DOI: 10.1016/0022-3468(95)90161-2  0.54
1995 Fisher WE, Boros LG, O'Dorisio TM, O'Dorisio MS, Schirmer WJ. GI hormonal changes in diabetes influence pancreatic cancer growth. The Journal of Surgical Research. 58: 754-8. PMID 7791356 DOI: 10.1006/Jsre.1995.1119  0.474
1995 Olsen JO, Pozderac RV, Hinkle G, Hill T, O'Dorisio TM, Schirmer WJ, Ellison EC, O'Dorisio MS. Somatostatin receptor imaging of neuroendocrine tumors with indium-111 pentetreotide (Octreoscan). Seminars in Nuclear Medicine. 25: 251-61. PMID 7570044 DOI: 10.1016/S0001-2998(95)80014-X  0.542
1995 Broner CW, O'Dorisio MS, Rosenberg RB, O'Dorisio TM. Cyclic nucleotides and vasoactive intestinal peptide production in a rabbit model of Escherichia coli septicemia. The American Journal of the Medical Sciences. 309: 267-77. PMID 7537447  0.421
1994 O'Dorisio MS, Chen F, O'Dorisio TM, Wray D, Qualman SJ. Characterization of somatostatin receptors on human neuroblastoma tumors. Cell Growth & Differentiation : the Molecular Biology Journal of the American Association For Cancer Research. 5: 1-8. PMID 8123588  0.554
1994 Schirmer TP, O'Dorisio TM, Olsen JO, Hinkle GH, O'Dorisio MS, Schirmer WJ. Influence of isotope dose on somatostatin receptor imaging: when less is better. Seminars in Oncology. 21: 51-5. PMID 7992082  0.438
1994 Woltering EA, Barrie R, O'Dorisio TM, O'Dorisio MS, Nance R, Cook DM. Detection of occult gastrinomas with iodine 125-labeled lanreotide and intraoperative gamma detection. Surgery. 116: 1139-46; discussion . PMID 7985099 DOI: 10.5555/Uri:Pii:0039606094903166  0.505
1993 Chen F, O'Dorisio MS, Hermann G, Hayes J, Malarkey WB, O'Dorisio TM. Mechanisms of action of long-acting analogs of somatostatin. Regulatory Peptides. 44: 285-95. PMID 8097891 DOI: 10.1016/0167-0115(93)90138-X  0.482
1992 Qualman SJ, O'Dorisio MS, Fleshman DJ, Shimada H, O'Dorisio TM. Neuroblastoma. Correlation of neuropeptide expression in tumor tissue with other prognostic factors. Cancer. 70: 2005-12. PMID 1381992 DOI: 10.1002/1097-0142(19921001)70:7<2005::Aid-Cncr2820700733>3.0.Co;2-H  0.494
1992 O'Dorisio MS, Fleshman DJ, Qualman SJ, O'Dorisio TM. Vasoactive intestinal peptide: autocrine growth factor in neuroblastoma. Regulatory Peptides. 37: 213-26. PMID 1313595 DOI: 10.1016/0167-0115(92)90616-3  0.574
1976 O'Dorisio MS, Barker KL. Effects of estradiol on the biosynthesis of pyridine nucleotide coenzymes in the rat uterus Biology of Reproduction. 15: 504-510. PMID 10018 DOI: 10.1095/Biolreprod15.4.504  0.585
1970 O'Dorisio MS, Barker KL. Effects of estradiol on the levels of pyridine nucleotide coenzymes in the rat uterus Endocrinology. 86: 1118-1126. PMID 4392223 DOI: 10.1210/Endo-86-5-1118  0.613
Show low-probability matches.